期刊文献+

冠状动脉支架内血栓形成患者牙周状况及细胞因子的变化

Periodontal condition and cytokine changes in patients with thrombus following coronary stenting
下载PDF
导出
摘要 目的:近年研究表明,炎症反应在动脉粥样硬化及其并发症的发生、发展中起着重要作用。观察冠状动脉支架置入后支架内血栓形成患者牙周状况和龈沟液中前列腺素E2、肿瘤坏死因子α、白细胞介素1,13水平变化。方法:选择2002-02/2008-05在辽宁医学院第一临床学院心内科行冠状动脉内支架置入后行冠状动脉造影复查的患者315例,其中出现支架内血栓形成的患者47例。比较冠状动脉支架置入后支架血栓形成患者与支架置入后正常患者的牙周状况,应用酶联免疫法测定龈沟液及血清中前列腺素E2、肿瘤坏死因子α、白细胞介素1,13水平。结果:支架内血栓形成患者牙周病的发病率显著高于支架正常的患者(41.7%,7.9%,P<0.01)。支架内血栓形成患者血清中前列腺素E2、肿瘤坏死因子α水平显著高于支架正常患者(P<0.01),白细胞介素1,13水平与支架正常患者差异无显著性意义(P>0.05)。支架内血栓形成患者龈沟液中前列腺素E2、肿瘤坏死因子α及白细胞介素1水平显著高于支架正常患者(P<0.01),白细胞介素13水平低于支架正常患者(P<0.01)。结论:牙周炎患者发生支架内血栓形成的概率明显高于未患牙周炎的患者,因此应加强冠状动脉内支架置入患者口腔疾病的防治。 AIM: Recent studies have shown that inflammatory reaction plays an important role in atherosclerosis and the incidence and progression of its complications. This study detected the change of the level of prostaglandin E2 (PGE2), tumor necrosis factor alpha (TNF-α), interleukin-1 (IL-1) and IL-13 in gingival crevicular fluid and the periodontal condition of patients undergoing coronary stenting. METHODS: 315 patients undergoing coronary arteriography following coronary stenting in Department of Cardiology, First Clinical College of Liaoning Medical University between February 2002 and May 2008 were selected, and 47 of them developed in-stent thrombus. The periodontal condition was compared between the patients with thrombus in stent and normal patients undergoing coronary stenting. The ELASE was used to detect the level of PGE2, TNF- α, IL-1 and IL-13 in the serum and gingival crevicular fluid. RESULTS: The incidence of periodontal disease in patients with thrombus in stent was significantly greater (41.7%, 7.9%, P 〈 0.01) and the level of PGE2 and TNF- α in serum was higher than patients without thrombus (P 〈 0.01). However, no significant difference was found in IL-1 and IL-13 between two groups (P〉 0,05). The levels of PGE2, TNF- α and IL-1 in gingival crevicular fluid were significantly greater in patients with thrombus in stent than patients with no thrombus (P 〈 0.01), while the level of IL-13 was lower than patients with no thrombus (P 〈 0.01). CONCLUSION: The incidence of thrombus in stent is high in patients with periodontal disease, so oral disease prevention is necessary for patients undergoing coronary stenting.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2009年第9期1645-1648,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献22

  • 1Li JY, Zhang YW. Zhonghua Xinxueguanbing Zazhi. 2006;34(11 ): 975-978. 被引量:1
  • 2韩雅玲,梁明,荆全民,王守力,马颖艳,栾波.52例冠状动脉支架内血栓形成患者的临床特点及介入治疗[J].中华心血管病杂志,2006,34(11):975-978. 被引量:34
  • 3中华人民共和国国务院.医疗机构管理条例,1994:26 被引量:301
  • 4Takahashi K, Takashiba S. Assessment ofinterlukin-6 in the pathogenesis of periodontal disease. J Periodontal.2004;65: 147-153. 被引量:1
  • 5Amitage GC, Wu YF. Low prevalence of a periodontitis-associated interleukin-1 composite genotype in individuals of Chinese heritage. J Periodontol. 2000;71 (2):164-171. 被引量:1
  • 6Grieve WG, Johnson GK, Moore RN, et al. Prostaglandin E (PGE) and interieukin-1 beta (IL-1 beta) levels in gingival crevicular fluid during human orthodontic tooth movement. Am J Orthod Dentofacial Orthop. 1994;105(4):369-174. 被引量:1
  • 7Geivelis M,Truner DW.Measturements of interleukin-6 in gingival crevicular fluid from patients with destructive periodomtal disease. J Periodontol.2003;64:980-983. 被引量:1
  • 8Rcinhardt RA,Masada MP, Homon C,et al.Gingical fluid IL-1 and IL-6 levels in refractory period-onritis. J Clin Periondontal.2005; 20:225-231. 被引量:1
  • 9Guillot JL,Rice GC.Gingival interleukin-6 concentation following Phase I therapy. J Periodotol.2005;8 667-672. 被引量:1
  • 10Balaguer-Malfagon JR, Pomar-Domingo F, Vilar-Herrero JV, et al. Stent thrombosis in the modern era: incidence, outcome and predictive factors. Rev Esp Cardiol.2006;59(8) :842-845. 被引量:1

二级参考文献11

  • 1韩雅玲,王守力,李毅,荆全民,马颖艳,王祖禄,王冬梅,栾波,王效增.急性冠状动脉综合征患者冠状动脉支架术前高负荷量氯吡格雷预治疗近期疗效[J].中国介入心脏病学杂志,2005,13(1):9-12. 被引量:53
  • 2Cutlip DE. Stent thrombosis: historical perspectives and current trends. J Thromb Thrombolysis, 2000, 10:89-101. 被引量:1
  • 3Honda Y, Fitzgerald PJ. Stent thrombosis: an issue revisited in a changing world. Circulation, 2003, 108 : 2-5. 被引量:1
  • 4Ischinger TA. Antithrombotics in interventional cardiology:optimizing treatment and strategies. Am J Cardiol, 1998, 82 : 25L-28L. 被引量:1
  • 5Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation, 2006, 113:1108-1113. 被引量:1
  • 6Farb A, Burke AP, Kolodgie FD, et al. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation, 2003,108:1701-1706. 被引量:1
  • 7Cheneau E, Leborgne L, Mintz GS, et al. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation, 2003, 108 : 4347. 被引量:1
  • 8Jeremias A, Sylvia B, Bridges J, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation, 2004,109 : 1930-1932. 被引量:1
  • 9La Vecchia L, Bedogni F, Vincenzi M. Subacute stent thrombosis occurring more than one month after implantation for acute myocardial infarction. Description of two cases successfully treated with angioplasty and further stenting. Cardiology, 1998, 90:305-308. 被引量:1
  • 10陈纪林,高润霖,杨跃进,乔树宾,徐波,秦学文,姚民,刘海波.冠状动脉支架内急性血栓形成的原因分析[J].中国循环杂志,1999,14(A09):13-15. 被引量:12

共引文献334

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部